This milestone marks significant progress toward the long-term goal of developing a nearly limitless source of clean energy through nuclear fusion. The Experimental Advanced Superconducting Tokamak ...

Credit: HFIPS China’s EAST project has set a new global record by maintaining a high-confinement plasma state for over 17 minutes, paving the way for future clean energy solutions by mimicking the sun ...

The new world record marks a “notable breakthrough” in the race to provide humanity with clean and plentiful fusion energy, China’s Institute of Plasma Physics (ASIPP) claims. Scientists behind the ...

If we want to rely on nuclear fusion to power the world's homes, the first step is making reactors that can run as hot and as long as possible. Now, China's 'artificial sun' reactor ...

Chinese scientists say they have achieved a new milestone in the pursuit of viable power generation through nuclear fusion, seen as the Holy Grail for clean energy. The Chinese Academy of Sciences ...

The nasal spray Spravato, which is made from the drug esketamine, had been approved in 2019 for patients who failed to respond to at least two oral antidepressants. However, it had to be used in ...

Programme is part of mission to build world’s first nuclear fusion plant in the UK A particle accelerator in Oxfordshire is to rip up atoms to generate a crucial element for nuclear fusion ...

This week, the Food and Drug Administration approved Johnson & Johnson’s ketamine-based nasal spray, Spravato, as a standalone therapy for cases of depression that haven’t responded to other ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the standalone treatment of major depressive disorder (MDD), PTSD ...

Jan. 21 (UPI) --The Food and Drug Administration has approved the first-ever stand-alone nasal spray to treat drug-resistant depression. Johnson & Johnson's Spravato has been approved to treat a ...

The Food and Drug Administration (FDA) approved Johnson & Johnson's ketamine-derived nasal spray to help millions of U.S. patients suffering from severe depression. Spravato, approved as a ...

NEW YORK (PIX11) – A nose spray has been approved by the U.S. Food and Drug Administration to help treat depression, Johnson & Johnson announced on Tuesday. Spravato is a first-of-its-kind ...